Absci Corp (NYSE: ABSI) — Healthcare · Share Price, Chart & Market Data
About: Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.53 (+15.05%)
ABSIAbsci Corp
Loading watchlist status…
Trade ABSI now
Absci Corp share price
ABSI price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 4:25 pm GMT+0
ABSI price performance
16.231%
5D
63.058%
1M
25.568%
YTD
42.1%
1Y
ABSI price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 4:25 pm GMT+0
ABSI details
ABSI Market Signals